Evaluation of the safety, immunogenicity and efficacy of a new live-attenuated lumpy skin disease vaccine in India

Lumpy skin disease (LSD) was reported for the first time in India in 2019 and since then, it has become endemic. Since a homologous (LSD-virus based) vaccine was not available in the country, goatpox virus (GPV)-based heterologous vaccine was authorized for mass immunization against LSD in cattle. This study describes the evaluation of safety, immunogenicity and efficacy of a new live-attenuated LSD vaccine developed using an Indian field strain (LSDV/India/2019/Ranchi). The virus was attenuated by continuous passage (P=50) in Vero cells. The vaccine (50th LSDV passage in Vero cells, named as Lumpi-ProVacInd) did not induce any local or systemic reaction upon its experimental inoculation in calves (n=10). At day 30 post-vaccination (pv), the vaccinated animals were shown to develop antibody- and cell-mediated immune response and exhibited complete protection upon virulent LSDV challenge. We observed a minimum Neethling response (0.018% animals; 5 out of 26940 animals) of the vaccine in field trials among 26940 animals. There was no significant reduction in the milk yield in lactating animals (n=10108), besides there was no abortion or any other reproductive disorder in the pregnant animals (n=2889). Sero-conversion was observed in 85.18% animals in the field by day 30 pv.

[1]  B. N. Tripathi,et al.  A serious skin virus epidemic sweeping through the Indian subcontinent is a threat to the livelihood of farmers , 2022, Virulence.

[2]  K. Sultankulova,et al.  LUMPY SKIN DISEASE VIRUS: APPROACHES TO ATTENUATION FOR VACCINE DEVELOPMENT , 2022, Eurasian Journal of Applied Biotechnology.

[3]  A. Gaber,et al.  Assessment of heterologous lumpy skin disease vaccine-induced immunity in pregnant cattle vaccinated at different times of gestation period and their influence on maternally derived antibodies. , 2022, Veterinary immunology and immunopathology.

[4]  F. Conraths,et al.  Review: Vaccines and Vaccination against Lumpy Skin Disease , 2021, Vaccines.

[5]  C. Saegerman,et al.  Comparative Evaluation of Lumpy Skin Disease Virus-Based Live Attenuated Vaccines , 2021, Vaccines.

[6]  O. Fassi Fihri,et al.  Capripoxvirus Infections in Ruminants: A Review , 2021, Microorganisms.

[7]  F. Namazi,et al.  Lumpy skin disease, an emerging transboundary viral disease: A review , 2021, Veterinary medicine and science.

[8]  B. N. Tripathi,et al.  Isolation and characterization of lumpy skin disease virus from cattle in India , 2020, bioRxiv.

[9]  K. Tadlaoui,et al.  Experimental evaluation of the cross-protection between Sheeppox and bovine Lumpy skin vaccines , 2020, Scientific Reports.

[10]  I. Haga,et al.  Lumpy Skin Disease Is Characterized by Severe Multifocal Dermatitis With Necrotizing Fibrinoid Vasculitis Following Experimental Infection , 2020, Veterinary pathology.

[11]  S. Babiuk,et al.  Potential of Using Capripoxvirus Vectored Vaccines Against Arboviruses in Sheep, Goats, and Cattle , 2019, Front. Vet. Sci..

[12]  M. Beer,et al.  Experimental lumpy skin disease virus infection of cattle: comparison of a field strain and a vaccine strain , 2019, Archives of Virology.

[13]  Kononov Aleksandr,et al.  A real-time PCR screening assay for the universal detection of lumpy skin disease virus DNA , 2019, BMC Research Notes.

[14]  L. Babiuk,et al.  Extended sequencing of vaccine and wild-type capripoxvirus isolates provides insights into genes modulating virulence and host range. , 2019, Transboundary and emerging diseases.

[15]  P. Calistri,et al.  Field observations and experiences gained from the implementation of control measures against lumpy skin disease in South-East Europe between 2015 and 2017. , 2020, Preventive veterinary medicine.

[16]  S. Gubbins,et al.  Neethling vaccine proved highly effective in controlling lumpy skin disease epidemics in the Balkans. , 2020, Preventive veterinary medicine.

[17]  M. Kafafy,et al.  Preparation of trivalent vaccine against lumpy skin disease using different capripox viral strain , 2018, Veterinary Medical Journal (Giza).

[18]  S. Babiuk,et al.  Colostrum transfer of neutralizing antibodies against lumpy skin disease virus from vaccinated cows to their calves , 2018, Transboundary and emerging diseases.

[19]  F. Abdallah,et al.  Sporadic cases of lumpy skin disease among cattle in Sharkia province, Egypt: Genetic characterization of lumpy skin disease virus isolates and pathological findings , 2018, Veterinary world.

[20]  A. Allepuz,et al.  Economic cost of lumpy skin disease outbreaks in three Balkan countries: Albania, Bulgaria and the Former Yugoslav Republic of Macedonia (2016‐2017) , 2018, Transboundary and emerging diseases.

[21]  Shalini Sharma,et al.  Virological and Immunological Outcomes of Coinfections , 2018, Clinical Microbiology Reviews.

[22]  S. Abutarbush,et al.  Serological and clinical evaluation of the Yugoslavian RM65 sheep pox strain vaccine use in cattle against lumpy skin disease , 2018, Transboundary and emerging diseases.

[23]  N. Krešić,et al.  Complete Genome Sequence of a Lumpy Skin Disease Virus Strain Isolated from the Skin of a Vaccinated Animal , 2018, Genome Announcements.

[24]  N. Krešić,et al.  Detection of lumpy skin disease virus in skin lesions, blood, nasal swabs and milk following preventive vaccination. , 2018, Transboundary and emerging diseases.

[25]  Z. Polizopoulou,et al.  Investigation on the incidence of adverse reactions, viraemia and haematological changes following field immunization of cattle using a live attenuated vaccine against lumpy skin disease , 2018, Transboundary and emerging diseases.

[26]  A. Azadmehr,et al.  Immune response characteristics of Capri pox virus vaccines following emergency vaccination of cattle against lumpy skin disease virus , 2018 .

[27]  Shalini Sharma,et al.  Emetine inhibits replication of RNA and DNA viruses without generating drug‐resistant virus variants , 2017, Antiviral research.

[28]  M. Şevik,et al.  Epidemiological and Molecular Studies on Lumpy Skin Disease Outbreaks in Turkey during 2014–2015 , 2017, Transboundary and emerging diseases.

[29]  L. Babiuk,et al.  Review: Capripoxvirus Diseases: Current Status and Opportunities for Control , 2015, Transboundary and emerging diseases.

[30]  M. Saad,et al.  Efficacy of Alternative Vaccination with Attenuated Sheep Pox and Inactivated Lumpy Skin Disease Vaccines against Lumpy Skin Disease , 2016 .

[31]  M. Abdelwahab,et al.  Preparation and field evaluation of live attenuated sheep pox vaccine for protection of calves against lumpy skin disease , 2016 .

[32]  A. Azadmehr,et al.  Evaluation of Humoral and Cell-mediated Immunity of Two Capripoxvirus Vaccine Strains against Lumpy Skin Disease Virus , 2016 .

[33]  K. Tadlaoui,et al.  Comparative innocuity and efficacy of live and inactivated sheeppox vaccines , 2016, BMC Veterinary Research.

[34]  S. Abutarbush,et al.  Adverse Reactions to Field Vaccination Against Lumpy Skin Disease in Jordan. , 2016, Transboundary and emerging diseases.

[35]  S. Abutarbush,et al.  Lumpy Skin Disease in Jordan: Disease Emergence, Clinical Signs, Complications and Preliminary-associated Economic Losses. , 2015, Transboundary and emerging diseases.

[36]  Y. Stram,et al.  Comparison of the efficacy of Neethling lumpy skin disease virus and x10RM65 sheep-pox live attenuated vaccines for the prevention of lumpy skin disease - The results of a randomized controlled field study. , 2015, Vaccine.

[37]  F. Roger,et al.  Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus. , 2015, Vaccine.

[38]  M. Esteban,et al.  The Evolution of Poxvirus Vaccines , 2015, Viruses.

[39]  P. Mertens,et al.  Characterization of sheep pox virus vaccine for cattle against lumpy skin disease virus , 2014, Antiviral research.

[40]  S. Abutarbush.  Efficacy of vaccination against lumpy skin disease in Jordanian cattle , 2014, Veterinary Record.

[41]  A. Wadhwa,et al.  Isolation and phylogenetic analysis of an orf virus from sheep in Makhdoom, India , 2013, Virus Genes.

[42]  E. Gelaye,et al.  Lumpy skin disease: preliminary vaccine efficacy assessment and overview on outbreak impact in dairy cattle at Debre Zeit, central Ethiopia. , 2013, Antiviral research.

[43]  C. Oura,et al.  Review: lumpy skin disease: an emerging threat to Europe, the Middle East and Asia. , 2012, Transboundary and emerging diseases.

[44]  E. Albina,et al.  Use of the Capripoxvirus homologue of Vaccinia virus 30 kDa RNA polymerase subunit (RPO30) gene as a novel diagnostic and genotyping target: development of a classical PCR method to differentiate Goat poxvirus from Sheep poxvirus. , 2011, Veterinary microbiology.

[45]  C. Embury-Hyatt,et al.  Quantification of lumpy skin disease virus following experimental infection in cattle. , 2008, Transboundary and emerging diseases.

[46]  J. Woods.  Lumpy skin disease—A review , 1988, Tropical Animal Health and Production.

[47]  V. Bhanuprakash,et al.  A Classical Live Attenuated Vaccine for Sheep Pox , 2004, Tropical Animal Health and Production.

[48]  G. Viljoen,et al.  Comparative sequence analysis of the South African vaccine strain and two virulent field isolates of Lumpy skin disease virus , 2003, Archives of Virology.

[49]  R. Kitching.  Vaccines for lumpy skin disease, sheep pox and goat pox. , 2003, Developments in biologicals.

[50]  T. Rao,et al.  A comprehensive review of goat pox and sheep pox and their diagnosis , 2000, Animal Health Research Reviews.

[51]  O. Nir,et al.  Spread of lumpy skin disease in Israeli dairy herds , 1995, Veterinary Record.

[52]  R. Hay.  Skin disease. , 1993, British medical bulletin.

[53]  B. Barnard,et al.  A study of the pathology of lumpy skin disease in cattle. , 1982, The Onderstepoort journal of veterinary research.